Canada Hematology Market Outlook to 2024

Published : Nov-2017

No. of Pages : 88

order by fax Inquire before Buying request discount

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 What Is This Report About? 6
2.2 Hematology Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7

3 Hematology Market, Canada 11
3.1 Hematology Market, Canada, Revenue ($m), 2010-2017 11
3.2 Hematology Market, Canada, Revenue ($m), 2017-2024 13
3.2.1 Hematology Analyzers Market, Canada, Revenue ($m), by Segment, 2010-2017 15
3.2.2 Hematology Cell Counters Market, Canada, Revenue ($m), by Segment, 2010-2017 17
3.2.3 Hematology Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2010-2017 19
3.2.4 Hematology Reagents Market, Canada, Revenue ($m), by Segment, 2010-2017 21
3.2.5 Hemostasis Market, Canada, Revenue ($m), by Segment, 2010-2017 23
3.2.6 Immunohematology Market, Canada, Revenue ($m), by Segment, 2010-2017 25
3.2.7 Hematology Analyzers Market, Canada, Revenue ($m), by Segment, 2017-2024 27
3.2.8 Hematology Cell Counters Market, Canada, Revenue ($m), by Segment, 2017-2024 29
3.2.9 Hematology Rapid Tests & POC Market, Canada, Revenue ($m), by Segment, 2017-2024 31
3.2.10 Hematology Reagents Market, Canada, Revenue ($m), by Segment, 2017-2024 33
3.2.11 Hemostasis Market, Canada, Revenue ($m), by Segment, 2017-2024 35
3.2.12 Immunohematology Market, Canada, Revenue ($m), by Segment, 2017-2024 37
3.3 Hematology Market, Canada, Volume (Units), 2010-2017 39
3.4 Hematology Market, Canada, Volume (Units), 2017-2024 41
3.4.1 Hematology Analyzers Market, Canada, Volume (Units), by Segment, 2010-2017 43
3.4.2 Hematology Rapid Tests & POC Market, Canada, Volume (Units), by Segment, 2010-2017 45
3.4.3 Hematology Reagents Market, Canada, Volume (Units), by Segment, 2010-2017 47
3.4.4 Hemostasis Market, Canada, Volume (Units), by Segment, 2010-2017 49
3.4.5 Hematology Analyzers Market, Canada, Volume (Units), by Segment, 2017-2024 51
3.4.6 Hematology Rapid Tests & POC Market, Canada, Volume (Units), by Segment, 2017-2024 53
3.4.7 Hematology Reagents Market, Canada, Volume (Units), by Segment, 2017-2024 55
3.4.8 Hemostasis Market, Canada, Volume (Units), by Segment, 2017-2024 57
3.5 Hematology Market, Canada, Average Price ($), 2010-2024 59
3.6 Hematology Market, Canada, Distribution Share by Revenue ($m), 2017 63
3.7 Hematology Market, Canada, Company Share by Revenue ($m), 2017 64

4 Overview of Key Companies in Canada, Hematology Market 66
4.1 Sysmex Corp 66
4.1.1 Company Overview 66
4.2 Abbott Laboratories 66
4.2.1 Company Overview 66
4.3 Beckman Coulter Inc 66
4.3.1 Company Overview 66
4.4 F. Hoffmann-La Roche Ltd 66
4.4.1 Company Overview 66
4.5 Sigma-Aldrich Corp 67
4.5.1 Company Overview 67
4.6 Siemens Healthcare GmbH 67
4.6.1 Company Overview 67
4.7 bioMerieux SA 67
4.7.1 Company Overview 67
4.8 Instrumentation Laboratory Company 67
4.8.1 Company Overview 67
4.9 Thermo Fisher Scientific Inc 68
4.9.1 Company Overview 68
4.10 Immucor, Inc. 68
4.10.1 Company Overview 68
4.11 Horiba Ltd 68
4.11.1 Company Overview 68
4.12 Sekisui Diagnostics LLC 69
4.12.1 Company Overview 69
4.13 Mindray Medical International Ltd 69
4.13.1 Company Overview 69
4.14 Grifols SA 69
4.14.1 Company Overview 69
4.15 Diagnostica Stago SAS 69
4.15.1 Company Overview 69

5 Hematology Market Pipeline Products 70

6 Financial Deals Landscape 71
6.1 Partnerships 71
6.1.1 Grifols and Beckman Coulter Enter into Distribution Agreement 71

7 Recent Developments 72
7.1 Corporate Communications 72
7.1.1 Jun 06, 2017: ProMIS Neurosciences Appoints William C. Mobley to Scientific Advisory Board 72
7.1.2 Mar 27, 2017: LightIntegra Board names Bill Dubiel as President and CEO 73
7.1.3 Mar 22, 2017: ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer 73
7.1.4 Mar 02, 2017: ProMIS Neurosciences announces appointment of Anthony Giovinazzo to its Board of Directors 73
7.2 Financial Announcements 74
7.2.1 Aug 11, 2017: ProMIS Neurosciences Announces Second Quarter 2017 Results 74
7.2.2 Jul 10, 2017: ProMIS Neurosciences Provides Second Quarter Update for 2017 76
7.2.3 May 09, 2017: ProMIS Neurosciences Announces Q1 2017 Quarterly Results 76
7.2.4 Mar 30, 2017: ProMIS Neurosciences announces overview of first quarter 2017 progress and outlook for near term value creation 77
7.2.5 Mar 15, 2017: ProMIS Neurosciences Announces Fiscal 2016 Annual Results 77
7.2.6 Nov 02, 2016: ProMIS Neurosciences Announces Third Quarter 2016 Results 78
7.3 Product News 80
7.3.1 Jul 31, 2017: Roche to showcase power of connected lab at AACC 2017 Clinical Lab Expo 80
7.4 Strategy And Business Planning 80
7.4.1 Jul 06, 2017: Rosetta Genomics Expands Patent Portfolio in Canada, United States, and China 80

8 Appendix 82
8.1 Research Methodology 83
8.1.1 Coverage 83
8.1.2 Secondary Research 83
8.1.3 Primary Research 84
8.1.4 Market Modeling and Forecasting 85
8.1.5 Company Share Analysis 86
8.1.6 Distribution Share Analysis 87
8.1.7 Benchmarking 87
8.2 GlobalData Consulting 87
8.3 Contact Us 88
8.4 Disclaimer 88

List of Tables

Table 1: Hematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 12
Table 2: Hematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 14
Table 3: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 4: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 18
Table 5: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 6: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 7: Hemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 8: Immunohematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 9: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 28
Table 10: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 30
Table 11: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 32
Table 12: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 13: Hemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 14: Immunohematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 15: Hematology Market, Canada, Volume (Units), Historic, 2010-2017 40
Table 16: Hematology Market, Canada, Volume (Units), Forecast, 2017-2024 42
Table 17: Hematology Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 44
Table 18: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 46
Table 19: Hematology Reagents Market, Canada, Volume (Units), Historic, 2010-2017 48
Table 20: Hemostasis Market, Canada, Volume (Units), Historic, 2010-2017 50
Table 21: Hematology Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 52
Table 22: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 54
Table 23: Hematology Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 56
Table 24: Hemostasis Market, Canada, Volume (Units), Forecast, 2017-2024 58
Table 25: Hematology Market, Canada, Average Price ($) Historic, 2010-2017 59
Table 26: Hematology Market, Canada, Average Price ($), Forecast, 2017-2024 61
Table 27: Hematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 63
Table 28: Hematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 65
Table 29: Hematology Market Pipeline Products 70
Table 30: Grifols and Beckman Coulter Enter into Distribution Agreement 71
Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 85

List of Figures

Figure 1: Hematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 11
Figure 2: Hematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 13
Figure 3: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 15
Figure 4: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 17
Figure 5: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 19
Figure 6: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 7: Hemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 8: Immunohematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 9: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 27
Figure 10: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 29
Figure 11: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 31
Figure 12: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 13: Hemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 14: Immunohematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 15: Hematology Market, Canada, Volume (Units), Historic, 2010-2017 39
Figure 16: Hematology Market, Canada, Volume (Units), Forecast, 2017-2024 41
Figure 17: Hematology Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 43
Figure 18: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 45
Figure 19: Hematology Reagents Market, Canada, Volume (Units), Historic, 2010-2017 47
Figure 20: Hemostasis Market, Canada, Volume (Units), Historic, 2010-2017 49
Figure 21: Hematology Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 51
Figure 22: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 53
Figure 23: Hematology Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 55
Figure 24: Hemostasis Market, Canada, Volume (Units), Forecast, 2017-2024 57
Figure 25: Hematology Market, Canada, Company Share (%) 2017 64

Filed in: Diagnostics

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027 “Increasing prevalence of infectious diseases and the rising funding for R&D are driving the overall growth of the infectious disease diagnostics market” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years. “The reagents, kits, and consumables accounted for the largest market share in the infectious disease diagnostics market, by product & service, during the forecast period” The infectious disease diagnostics......	$4950
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027 “The global in vitro toxicology testing market is projected to grow at a CAGR of 10.8%.” The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%.Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market “The ADME segment is expected to account for the largest market share in 2021.” Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endp......	$4950
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027 “Rising funding for R&D in molecular diagnostics and increasing prevalence of infectious diseases and cancer are driving the overall growth of the molecular diagnostics market” The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent. “The DNA sequencing & NGS segment accounted for the highest growth rate in the molec......	$4950
Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026 “The rising an essential precondition for operational excellence and accreditation in several industries is expected to drive the overall growth of the laboratory proficiency testing market.” The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%. With proficiency testing being a mandatory procedure to be undertaken by laboratories functioning in different industries which are under regulation by organizations such as the CLIA, APLAC, and CLSI, the market for proficiency testing is expected to witness significant growth during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the gro......	$4950
Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026 “The Liquid Handling System market is projected to grow at CAGR of 5.1% from 2021 to 2026” The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported by a favorable funding scenario. However, the slow adoption of automation among small and medium-sized laboratories may restrain the market growth. “Pipettes in the product segment to witness the highest growth during the forecast period.” Based on the products, the global liquid handling system market is segmented into Pipettes, Consum......	$4950
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026 The global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the f......	$4950
Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027 “Dearth of skilled laboratory technicians” The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government p......	$4950
Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026 The organ preservation market is expected to grow at a CAGR of 6.6% in the forecast period. The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%.Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent. “The University of Wisconsin (UW) holds the largest market share in the solution market.” Based on the Solution, the segment is divided ......	$4950
Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026 The medical refrigerators market was valued at USD 3.5 Billion in 2020 and is projected to reach USD 4.9 Billion by 2026, at a CAGR of 6.0% during the forecast period. The medical refrigerators market is on course for intense growth across different end use industries such as blood banks, pharmaceutical companies, hospitals, & pharmacies, research institutes, medical laboratories, and diagnostic centers. “The ultra-low temperature freezers segment, by value, is projected to grow at the highest CAGR during the forecast period” By product type, ultra-low temperature freezers segment is expected to grow at the highest CAGR during 2021 to 2026, by value. Ultra-low temperature freezers (ULT freezers) are used for the storage of drugs, enzymes, chemicals, bacteria, viruses, cell pr......	$4950
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026 “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market gr......	$4950

Canada Hematology Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027

Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026

Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026

In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026

Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026

Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026